Fused Heteroaryl Compounds for Selective Sodium Channel Modulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for neurological and cardiac conditions associated with abnormal late or persistent sodium current (INaL) are inadequate, as they often fail to selectively modulate sodium channel activity effectively.

Innovation Solution

Development of fused heteroaryl compounds and compositions that can selectively modulate sodium channel activity, specifically targeting abnormal INaL, to treat conditions related to aberrant sodium ion channel function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current treatments are used for neurological and cardiac conditions, then they are administered to patients, but they fail to selectively modulate sodium channel activity effectively

Engineering Contradiction:
Improveselectivity of sodium channel modulationVSAvoideffectiveness of treatment
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent applies local quality by designing compounds with specific structural features (fused heteroaryl rings with particular substituent patterns) that confer selective affinity for abnormal sodium channel states. The molecular structure incorporates specific functional groups and ring systems that interact preferentially with pathological sodium channels while sparing normal channels, achieving selective modulation through localized molecular properties.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs parameter changes by systematically varying molecular parameters such as ring size, substituent types, and molecular configuration to optimize selectivity for abnormal sodium channels. By adjusting these chemical parameters, the compounds achieve differential binding affinity for pathological versus normal sodium channel states, resolving the contradiction between selectivity and effectiveness.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If fused heteroaryl compounds are developed to selectively modulate sodium channel activity, then they can target abnormal INaL, but the complexity of compound structure increases

Engineering Contradiction:
Improveselectivity for abnormal INaLVSAvoidmolecular structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the molecular structure into distinct functional modules: a core fused heteroaryl ring system, specific substituent groups at defined positions, and linker moieties. This modular segmentation allows systematic optimization of selectivity while maintaining manageable structural complexity through organized functional domains.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs composite materials principles by combining different heteroaryl ring systems with specific substituent patterns to create composite molecular structures. These composite compounds integrate multiple functional elements that work synergistically to achieve selective binding to abnormal sodium channels, balancing enhanced selectivity with controlled molecular complexity.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS20250145629A1Ion channel modulators
Publication Date: 2025.05.08 PRAXIS PRECISION MEDICINES INC
  • US20250145629A1 patent drawing
  • US20250145629A1 patent drawing
  • US20250145629A1 patent drawing

AI summary

The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.